Centerline Biomedical announced that it closed a $33 million Series B equity financing, led by Cleveland Clinic.
GE Healthcare, RIK Enterprises, JobsOhio, Jumpstart Ventures and G2 Group Ventures all participated in the financing, which will be used to help propel the Cleveland-based company into new surgical applications, accelerate its commercial sales and add to its growing clinical evidence repository.
“Our technology is already yielding excellent clinical benefits and this funding will help realize our mission of improving the outcomes, radiation safety and accuracy in endovascular surgery,” Centerline CEO Philip D. Rackliffe said in a news release. “Successfully raising this capital given the challenging global environment is a resounding testament to this technology and incredible team at Centerline”.
Centerline Biomedical’s flagship product, the IOPS (intra-operative positioning system) was developed in Cleveland Cl…